awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38693146-97744F58-BE93-4E74-81AB-912F38D46AAE
Q38693146-97744F58-BE93-4E74-81AB-912F38D46AAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38693146-97744F58-BE93-4E74-81AB-912F38D46AAE
PharmGKB summary: pazopanib pathway, pharmacokinetics.
P2860
Q38693146-97744F58-BE93-4E74-81AB-912F38D46AAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38693146-97744F58-BE93-4E74-81AB-912F38D46AAE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dc0b1c935d66fb52e5a4e10f9781e1b08f457fdf
P2860
Phase Ib trial of the oral angiogenesis inhibitor pazopanib administered concurrently with pemetrexed in patients with advanced solid tumors.